Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Fluent, Inc. Director's Dealing 2017

Nov 16, 2017

34456_dirs_2017-11-16_501fe2a3-5bd3-4a31-81db-2d46703ca18a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cogint, Inc. (COGT)
CIK: 0001460329
Period of Report: 2017-11-15

Reporting Person: FROST PHILLIP MD ET AL (Director, 10% Owner)
Reporting Person: Frost Gamma Investments Trust (10% Owner, Joint Filer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-15 Common Stock P 20000 $4.11 Acquired 15724874 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 3000000 Indirect
Common Stock 33333 Direct
Common Stock 16667 Direct

Footnotes

F1: The shares were purchased in multiple transactions at prices ranging from $4.00 to $4.20, with a weighted average price per share of $4.11. The reporting person undertakes to provide Cogint, Inc., any security holder of Cogint, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price with the ranges set forth in this footnote.

F2: These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and
exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of
Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole
shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any
pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities
for purposes of Section 16 or for any other purpose.

F3: On December 8, 2015, the reporting person received a grant, subject to stockholder approval, of 3,000,000 RSUs, convertible into common stock of the issuer on a one-for-one basis. Stockholder approval was obtained on June 1, 2016. The reporting person has elected to defer delivery of any vested RSUs until the reporting person's separation from service from the Company, a Change of Control of the Company, or death or disability.

F4: Represents Restricted Stock Units (RSUs) convertible into common stock of the issuer on a one-for-one basis. The RSUs vest in approximate equal installments on June 1, 2018 and 2019, subject to accelerated vesting under certain circumstances.